Vikram Vuppala | Photo credit: CV SUBRAHMANYAM
Dialysis provider NephroPlus is raising ₹850 crore from healthcare private equity firm Quadria Capital.
Quadria will acquire a significant minority stake through a combination of core investment and purchase of shares from existing shareholders. The transaction will support NephroPlus in meeting the growing demand for high-quality dialysis services at affordable prices in India and other markets in Asia.
“We look forward to expanding in India, our core market, while exploring further opportunities to make our expertise and clinical excellence available to more patients in other global markets. Quadria’s healthcare expertise, capital and focus on operational value creation will further position us to continue to scale, innovate and deliver affordable, high-quality care,” said NephroPlus Founder and CEO Vikram Vuppala in an announcement regarding the Series F round. fundraising.
Founded in 2010, NephroPlus operates approximately 450 dialysis centers in over 250 cities in India, the Philippines and Uzbekistan. It serves approximately 30,000 patients and performs over 3 million dialysis sessions each year.
“The investment in NephroPlus underlines our ambition to invest in regional Asian healthcare leaders who deliver high-quality, affordable healthcare to enormous underserved populations,” said Sunil Thakur, partner and head of South Asia at Quadria Capital.
